Prognostic Value of Caveolin-1 Expression in Gastric Cancer: a Meta-analysis |
Ye, Yang
(Department of Preventive Medicine, School of Medicine, Jiangsu University)
Miao, Shu-Han (Department of Health Care, the Fourth Affiliated Hospital of Jiangsu University) Lu, Rong-Zhu (Department of Preventive Medicine, School of Medicine, Jiangsu University) Zhou, Jian-Wei (Department of Molecular Cell Biology and Toxicology, Cancer Center, School of Public Health, Nanjing Medical University) |
1 | Bulanov D (2007). Gastric cancer - current state of the problem. Part I. Epidemiology. Pathology. Classification. Staging. Khirurgiia, 48-59 (in Bulgarian). |
2 | Anderson RG, Kamen BA, Rothberg KG, et al (1992). Potocytosis: sequestration and transport of small molecules by caveolae. Science, 255, 410-1. DOI |
3 | Barresi V, Giuffre G, Vitarelli E, et al (2008). Caveolin-1 immunoexpression in human gastric cancer: histopathogenetic hypotheses. Virchows Arch, 453, 571-8. DOI |
4 | Gao X, Sun Y, Huang L, et al (2005). Down-regulation of caveolin-1 in gastric carcinoma and its clinical biological significance. Ai Zheng, 24, 311-6 (in Chinese). |
5 | Goetz JG, Lajoie P, Wiseman SM, et al (2008). Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer Metastasis Rev, 27, 715-35. DOI |
6 | He Y, Zhao X, Gao J, et al (2012). Quantum dots-based immunofluorescent imaging of stromal fibroblasts caveolin-1 and light chain 3B expression and identification of their clinical significance in human gastric cancer. Int J Mol Sci, 13, 13764-80. DOI |
7 | Lee H, Volonte D, Galbiati F, et al (2000). Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol Endocrinol, 14, 1750-75. DOI |
8 | Li BR, Zhou GW, Bian Q, et al (2012). Lack of association between the hOGG1 Ser326Cys polymorphism and gastric cancer risk: a meta-analysis. Asian Pac J Cancer Prev, 13, 1145-9. DOI |
9 | Nam KH, Lee BL, Park JH, et al (2013). Caveolin 1 expression correlates with poor prognosis and focal adhesion kinase expression in gastric cancer. Pathobiology, 80, 87-94. DOI |
10 | Razani B, Engelman JA, Wang XB, et al (2001). Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem, 276, 38121-38. |
11 | Scherer PE, Lewis RY, Volonte D, et al (1997). Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem, 272, 29337-46. DOI ScienceOn |
12 | Sotgia F, Martinez-Outschoorn UE, Howell A, et al (2012). Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms. Annu Rev Pathol, 7, 423-67. DOI ScienceOn |
13 | Sun GY, Wu JX, Wu JS, et al (2012). Caveolin-1, E-cadherin and beta-catenin in gastric carcinoma, precancerous tissues and chronic non-atrophic gastritis. Chin J Cancer Res, 24, 23-8. DOI |
14 | Syeed N, Hussain F, Husain SA, et al (2012). 5'-CpG island promoter hypermethylation of the CAV-1 gene in breast cancer patients of Kashmir. Asian Pac J Cancer Prev, 13, 371-5. DOI |
15 | Wiechen K, Diatchenko L, Agoulnik A, et al (2001). Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol, 159, 1635-43. DOI ScienceOn |
16 | Williams TM, Lisanti MP (2005). Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol, 288, 494-506. |
17 | Zhao X, He Y, Gao J, et al (2013). Caveolin-1 expression level in cancer associated fibroblasts predicts outcome in gastric cancer. PLoS One, 8, 59102. DOI |